These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10770261)

  • 1. Comparison of the effect of blood pressure on the development of stroke, acute myocardial infarction, and end-stage renal disease.
    Iseki K; Kimura Y; Wakugami K; Okumura K; Muratani H; Ikemiya Y; Fukiyama K
    Hypertens Res; 2000 Mar; 23(2):143-9. PubMed ID: 10770261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal change in blood pressure and risk of end-stage renal disease in a community-based cohort in Okinawa.
    Usui T; Iseki C; Iseki K; Kawakami K; Nangaku M
    Clin Exp Nephrol; 2019 Nov; 23(11):1280-1287. PubMed ID: 31385160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for high incidence of end-stage renal disease in patients after stroke and acute myocardial infarction at age 60 or younger.
    Iseki K; Wakugami K; Maehara A; Tozawa M; Muratani H; Fukiyama K
    Am J Kidney Dis; 2001 Dec; 38(6):1235-9. PubMed ID: 11728955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between serum cholesterol and the risk of acute myocardial infarction in a screened cohort in Okinawa, Japan.
    Wakugami K; Iseki K; Kimura Y; Okumura K; Ikemiya Y; Muratani H; Fukiyama K
    Jpn Circ J; 1998 Jan; 62(1):7-14. PubMed ID: 9559412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
    Iseki K; Kinjo K; Iseki C; Takishita S
    Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
    Iseki K; Ikemiya Y; Kinjo K; Iseki C; Takishita S
    Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis.
    Tozawa M; Iseki K; Iseki C; Takishita S
    Kidney Int; 2002 Feb; 61(2):717-26. PubMed ID: 11849415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute risk score for stroke, myocardial infarction, and all cardiovascular disease: Japan Arteriosclerosis Longitudinal Study.
    Harada A; Ueshima H; Kinoshita Y; Miura K; Ohkubo T; Asayama K; Ohashi Y;
    Hypertens Res; 2019 Apr; 42(4):567-579. PubMed ID: 30760890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure targets for hypertension in people with diabetes mellitus.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2013 Oct; (10):CD008277. PubMed ID: 24170669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension control and the risk of myocardial infarction and stroke: a population-based study.
    al-Roomi KA; Heller RF; Wlodarczyk J
    Med J Aust; 1990 Nov; 153(10):595-9, 602-3. PubMed ID: 2233433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L
    J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure and risk of end-stage renal disease in a screened cohort.
    Iseki K; Ikemiya Y; Fukiyama K
    Kidney Int Suppl; 1996 Jun; 55():S69-71. PubMed ID: 8743514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of developing end-stage renal disease in a cohort of mass screening.
    Iseki K; Iseki C; Ikemiya Y; Fukiyama K
    Kidney Int; 1996 Mar; 49(3):800-5. PubMed ID: 8648923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of uncontrolled blood pressure in apparent treatment-resistant hypertension with increased risk of major adverse cardiovascular events plus.
    Bakris G; Chen C; Campbell AK; Ashton V; Haskell L; Singhal M
    J Clin Hypertens (Greenwich); 2023 Aug; 25(8):737-747. PubMed ID: 37461262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort.
    Iseki K; Tozawa M; Ikemiya Y; Kinjo K; Iseki C; Takishita S
    Clin Exp Nephrol; 2005 Mar; 9(1):46-52. PubMed ID: 15830273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP).
    Peralta CA; Norris KC; Li S; Chang TI; Tamura MK; Jolly SE; Bakris G; McCullough PA; Shlipak M;
    Arch Intern Med; 2012 Jan; 172(1):41-7. PubMed ID: 22232147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index and the risk of development of end-stage renal disease in a screened cohort.
    Iseki K; Ikemiya Y; Kinjo K; Inoue T; Iseki C; Takishita S
    Kidney Int; 2004 May; 65(5):1870-6. PubMed ID: 15086929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic difference in the prevalence of chronic kidney disease among Japanese screened subjects: Ibaraki versus Okinawa.
    Iseki K; Horio M; Imai E; Matsuo S; Yamagata K
    Clin Exp Nephrol; 2009 Feb; 13(1):44-9. PubMed ID: 18854923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.